GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New PartnersBusiness Wire • 12/05/24
Biogen Inc. (BIIB) Presents at 7th Annual Evercore ISI HealthCONx Healthcare Conference Call TranscriptSeeking Alpha • 12/03/24
These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost OverThe Motley Fool • 11/26/24
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation UpsideBenzinga • 11/20/24
Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease ActivityGlobeNewsWire • 11/19/24
Samsung Bioepis and Biogen Receive European Commission (EC) Approval for Aflibercept Biosimilar, OPUVIZ™GlobeNewsWire • 11/18/24
Biogen Partner Eisai Gets Positive CHMP Nod for Leqembi in EuropeZacks Investment Research • 11/15/24
Biogen's stock rises after E.U. regulator reverses negative view of Alzheimer's drugMarket Watch • 11/14/24
Biogen (BIIB) Loses -6.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 11/04/24
Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer's Disease (CTAD) ConferenceGlobeNewsWire • 10/30/24